These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. McGowan I, Taylor DJ. Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687 [Abstract] [Full Text] [Related]
25. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences. Hardy E, Hebling EM, Sousa MH, Almeida AF, Amaral E. Contraception; 2007 Aug; 76(2):126-31. PubMed ID: 17656182 [Abstract] [Full Text] [Related]
29. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India. Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM. Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909 [Abstract] [Full Text] [Related]
30. Woman-initiated methods for HIV prevention. Stein Z. GMHC Treat Issues; 1997 Jun; 11(7-8):20-2. PubMed ID: 11364646 [Abstract] [Full Text] [Related]
31. Female condom use among women at high risk of sexually transmitted disease. Macaluso M, Demand M, Artz L, Fleenor M, Robey L, Kelaghan J, Cabral R, Hook EW. Fam Plann Perspect; 2000 Jun; 32(3):138-44. PubMed ID: 10894260 [Abstract] [Full Text] [Related]
32. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men. Veldhuijzen N, Nyinawabega J, Umulisa M, Kankindi B, Geubbels E, Basinga P, Vyankandondera J, Van De Wijgert J. Cult Health Sex; 2006 Jun; 8(5):395-406. PubMed ID: 16923644 [Abstract] [Full Text] [Related]
34. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. Sahin-Hodoglugil NN, Montgomery E, Kacanek D, Morar N, Mtetwa S, Nkala B, Philip J, Ramjee G, Cheng H, van der Straten A, The Mira Team. AIDS Care; 2011 Aug; 23(8):1026-34. PubMed ID: 21480005 [Abstract] [Full Text] [Related]
36. Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories. Zaveri T, Powell KA, Guthrie KM, Bakke AJ, Ziegler GR, Hayes JE. BMC Womens Health; 2018 Oct 20; 18(1):170. PubMed ID: 30342510 [Abstract] [Full Text] [Related]
37. Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in south-western Uganda. Hart GJ, Pool R, Green G, Harrison S, Nyanzi S, Whitworth JA. AIDS Care; 1999 Dec 20; 11(6):687-98. PubMed ID: 10716009 [Abstract] [Full Text] [Related]
38. [Contraceptives, HIV, and other sexually transmitted diseases]. Vandale-Toney S, Conde-González CJ. Ginecol Obstet Mex; 1995 Jan 20; 63():40-5. PubMed ID: 7896158 [Abstract] [Full Text] [Related]
40. Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners. Trottier S, Omar RF, Désormeaux A, Drouin J, Gagnon MT, Vezina F, Guilbert E, Mâsse B, Bergeron MG. Contraception; 2007 Aug 20; 76(2):117-25. PubMed ID: 17656181 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]